Company Filing History:
Years Active: 2006-2008
Title: Kristin P Ollis: Innovator in Apoptosis Research
Introduction
Kristin P Ollis is a prominent inventor based in San Diego, CA. She has made significant contributions to the field of apoptosis research, focusing on the development of novel compounds that can induce cell death in abnormal cells. With a total of three patents to her name, her work is paving the way for advancements in clinical treatments.
Latest Patents
Kristin's latest patents include a method of using substituted 3-aryl-5-aryl-[1,2,4]-oxadiazoles and analogs as activators of caspases and inducers of apoptosis. This invention is directed towards compounds that can effectively induce cell death in various clinical conditions characterized by uncontrolled cell growth. Another notable patent involves derivatives of gambogic acid and their analogs, which also serve as activators of caspases and inducers of apoptosis. These discoveries highlight the potential of her inventions in addressing serious health issues.
Career Highlights
Kristin P Ollis has established herself as a key figure in her field through her innovative research and patent contributions. Her work at Cytovia, Inc. has allowed her to explore the therapeutic applications of her inventions, contributing to the advancement of medical science.
Collaborations
Kristin collaborates with esteemed colleagues such as Sui Xiong Cai and Han-Zhong Zhang. Their combined expertise enhances the research efforts at Cytovia, Inc., fostering an environment of innovation and discovery.
Conclusion
Kristin P Ollis is a trailblazer in the field of apoptosis research, with her patents reflecting her commitment to advancing medical treatments. Her work continues to inspire and pave the way for future innovations in the industry.